Linaclotide News

← Back to News Overview

---

Linaclotide currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Linaclotide with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Original indication: Constella is indicated for the symptomatic treatment of moderate to severe irritable-bowel syndrome with constipation (IBS-C) in adults.
• Evidence level: L5
• Predicted indications (20):
  • cauda equina syndrome (100.0%)
  • irritable bowel syndrome (99.9%)
  • obsolete neurogenic bladder (disease) (99.9%)
  • insomnia (disease) (99.5%)
  • neurocirculatory asthenia (99.2%)
  • autonomic nervous system disease (98.8%)
  • familial mitral valve prolapse (97.8%)
  • mitral valve prolapse (disease) (97.5%)
  • MVP1 (96.9%)
  • gastroduodenitis (96.5%)
  • large intestine disease (95.1%)
  • rhinitis (94.7%)
  • small intestine disease (94.5%)
  • peptic ulcer disease (94.0%)
  • dysautonomia (94.0%)
  • gastroenteritis (92.9%)
  • active vestibular Meniere disease (89.8%)
  • active cochlear Meniere disease (89.8%)
  • active cochleovestibular Meniere disease (89.8%)
  • vertigo, benign recurrent, 2 (89.5%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.